NASDAQ: ESPR Long Term Investor Notice: Investigation of Potential Wrongdoing at Esperion Therapeutics, Inc.
October 22, 2018 at 13:00 PM EDT
San Diego, CA -- (SBWIRE) -- 10/22/2018 -- An investigation was announced for investors in shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) over possible breaches of fiduciary duties by certain directors and officers of Esperion Therapeutics, Inc..
